Ortho-Clinical Diagnostic has agreed to pay $19.5 million to resolve a class action alleging that it conspired with another company to fix prices on the reagents used in blood tests. Ortho-Clinical’s $19.5 million will be combined with a $22 million settlement that Immucor Inc. agreed to pay to resolve allegations against it, bringing the total settlement fund to $41.5 million. Continue reading “Blood Reagents Antitrust Class Action Settles”